Ignite Creation Date:
2024-05-06 @ 12:48 AM
Last Modification Date:
2024-10-26 @ 10:55 AM
Study NCT ID:
NCT01666912
Status:
COMPLETED
Last Update Posted:
2017-05-01
First Post:
2012-08-14
Brief Title:
Postpartum Etonogestrel Implant for Adolescents
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Study Overview
Official Title:
Etonogestrel-releasing Subdermal Implant for Adolescents in the Postpartum Period a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PPImplant
Brief Summary:
This is a prospective study comparing two groups of 48 adolescent women each The intervention group will receive a contraceptive implant postpartum prior to discharge from the hospital The control group will receive a contraceptive implant at the usual 6 week postpartum clinic visit During prenatal care participants will be consented and screened for enrollment After delivery these women will be assessed and consented for enrollment into the study Women who consent for enrollment will be randomized Women will be followed up at 3 months 6 months 9 months and 1 year after contraceptive implant insertion At each follow up women will be assessed for continuation of and satisfaction with this method of contraception
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None